Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Policy & Politics

PEPFAR Reauthorization "Rests With Congress," OGAC Official Says

May 1, 2013

Speaking at a briefing on Tuesday at the Center for Strategic and International Studies (CSIS) in Washington, D.C., Deputy Global AIDS Coordinator Julia Martin said "[t]he decision about whether to reauthorize [PEPFAR] 'rests with Congress. ... Whether we move in that direction is yet to be fully determined but PEPFAR will continue at the will of Congress," CQ HealthBeat reports. "Many advocates assume that lawmakers are preoccupied with other international priorities and will not focus on PEPFAR enough to move a bill," the news service writes, adding, "Even without a reauthorization, the program can continue." The briefing, co-sponsored by CSIS and the Kaiser Family Foundation, focused on the Institute of Medicine's (IOM) Evaluation of PEPFAR, which was

View Full Article


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More News and Reports on U.S. Global HIV/AIDS Relief (PEPFAR)

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement